Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
ID: 350176Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $100K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Global Infectious Disease Research Administration Development Award, aimed at enhancing the grants management capabilities of research institutions in low- and middle-income countries (LMICs). This funding opportunity seeks to provide senior administrators from these institutions with advanced training in managing NIH grants, focusing on improving compliance and oversight of NIAID grant awards. The initiative is crucial for strengthening research infrastructure in LMICs, fostering collaborations between U.S. and foreign research organizations, and advancing global health initiatives. Eligible applicants can receive awards of up to $100,000 per year for a project period not exceeding two years, with applications due by March 13, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is inviting applications for the Global Infectious Disease Research Administration Development Award aimed at enhancing grants management capabilities for research institutions in low- and middle-income countries (LMICs). The initiative seeks to provide senior administrators from these institutions with advanced training in managing NIH grants, specifically focusing on improving compliance and oversight of NIAID grant awards. The funding opportunity allows for awards up to $100,000 per year, with a project period not to exceed two years. Key components of the application include a Research Grants Administration Plan, Staff Training Plan, and a Long-Term Plan, supplemented by letters of support from both the LMIC and U.S. institutions involved. The program encourages institutions to adopt best practices in grants management, enhance operational efficiency, and foster an environment conducive to research activities. This opportunity reflects the NIH's commitment to strengthening research infrastructure in LMICs to advance global health initiatives and enhance collaborations between U.S. and foreign research organizations. Applications must be submitted electronically, adhering to specific timelines and application requirements outlined in the notice of funding opportunity.
    Similar Opportunities
    Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Global Infectious Disease Research Training Program (D43 Clinical Trial Optional), aimed at enhancing research capacity in low- and middle-income countries (LMICs) regarding infectious diseases. This program encourages collaborative applications from U.S. and LMIC institutions, focusing on critical areas such as neglected tropical diseases and co-infections in HIV patients, while excluding HIV/AIDS as a primary focus. Successful applicants will develop structured training curricula, mentorship pairings, and research skills relevant to local health priorities, with annual budgets capped at $230,000 for a maximum project period of five years. Interested parties should note that the application deadline is August 6, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    LAUNCHing Leaders for Future U.S. Investments in Global Health Research (D43 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "LAUNCHing Leaders for Future U.S. Investments in Global Health Research," aimed at supporting the training of early career researchers in global health. This program seeks consortia of four U.S. research institutions and at least six collaborating research-intensive institutions in low- and middle-income countries (LMICs) to develop one-year mentored research training programs that focus on biomedical or behavioral science relevant to NIH research priorities. The initiative is designed to enhance the potential of future researchers to address health needs both in the U.S. and globally, providing mentorship, skills training, and networking opportunities. Interested applicants can reach out to UnJa Hayes at unja.hayes@nih.gov or call 301-827-7024 for more information, with the estimated project start date set for July 1, 2027, and key deadlines for synopsis posting and closing occurring in March and May 2026, respectively.
    Emerging Global Leader Award (K43 Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Emerging Global Leader Award (K43), a federal grant aimed at supporting early-career research scientists from low- or middle-income countries (LMICs) to conduct independent clinical trials. Eligible applicants must hold junior faculty positions at LMIC institutions and propose career development activities alongside health-related research projects that align with national priorities, fostering global research collaboration through mentorship from both LMIC and U.S. institutions. This program is crucial for enhancing scientific capacity in LMICs and addressing significant health challenges, providing funding of up to $100,000 for salary and an additional $40,000 per year for research-related expenses over a period of three to five years. The application period opens on November 3, 2024, with a final deadline of December 4, 2026; for more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Emerging Global Leader Award (K43), a grant aimed at enhancing the research capacity of early-career scientists from low- and middle-income countries (LMICs). This funding opportunity is designed for junior faculty members at LMIC institutions who propose research aligned with their country's health priorities, while specifically excluding independent clinical trials. The award provides support for up to five years, covering salary and research-related expenses, with the expectation that recipients will dedicate 75% of their time to research and development activities. Interested applicants must submit their proposals by December 3, 2026, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants
    National Institutes of Health
    The National Institutes of Health (NIH) is offering exploratory grants under the Global Brain and Nervous System Disorders Research Across the Lifespan program, aimed at fostering collaborative neuro-health research between U.S. and low- and middle-income country (LMIC) organizations. The program encourages research across a wide spectrum of neuro-health issues, including neurological, neuropsychiatric, and neurodevelopmental diseases, with a focus on developing innovative and cost-effective interventions that address health needs both domestically and globally. Interested applicants, including Indian/Native American Tribal Governments and eligible agencies, must partner with at least one U.S. organization and one LMIC organization, with the estimated award date set for August 15, 2026. For further inquiries, potential applicants can contact UnJa Hayes at unja.hayes@nih.gov or by phone at 301-827-7024.
    International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the International Research Scientist Development Award (IRSDA) (K01), a federal grant aimed at supporting advanced postdoctoral U.S. research scientists and recently-appointed junior faculty in developing their careers in global health. Applicants are required to propose research projects that address health priorities in low- and middle-income countries (LMIC) while being mentored by both U.S. and LMIC-based mentors, committing at least 75% of their professional effort to the research. This program emphasizes the importance of fostering collaborative global health partnerships and aims to build a diverse global health workforce, providing up to $100,000 annually in salary and $40,000 for research development costs. Interested applicants must submit their proposals by March 9, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the International Research Scientist Development Award (IRSDA), a federal grant aimed at supporting advanced postdoctoral researchers and junior faculty from the U.S. in their career development through mentored research experiences in low- and middle-income countries (LMICs). Applicants must be at least two years post-doctorate and are required to propose research projects that align with the health priorities of the selected LMIC, working under the guidance of both U.S. and LMIC mentors. The award provides up to $100,000 annually for the recipient's salary and $40,000 for research-related expenses, with a funding period of three to five years. Interested applicants must submit their proposals by March 9, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-114.html.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.